552883-99-5Relevant academic research and scientific papers
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase
Tanis, Steven P.,Strohbach, Joseph W.,Parker, Timothy T.,Moon, Malcom W.,Thaisrivongs, Suvit,Perrault, William R.,Hopkins, Todd A.,Knechtel, Mary L.,Oien, Nancee L.,Wieber, Janet L.,Stephanski, Kevin J.,Wathen, Michael W.
scheme or table, p. 1994 - 2000 (2010/10/02)
Discovery efforts were focused on identifying a non-nucleoside antiviral for treating infections caused by human cytomegalovirus (HCMV) with equal or better potency and diminished toxicity compared to current therapeutics. This Letter describes the HCMV D
PYRIDOQUINOXALINE ANTIVIRALS
-
, (2008/06/13)
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof wherein R1 and R2 are as defined in the specification. The compounds are useful for the treatment of viral infections.
